Holen Sie sich die Stockscreener-App
96.36
1.49%
1.415
Schlusskurs vom Vortag:
$94.94
Offen:
$94.75
24-Stunden-Volumen:
395
Relative Volume:
0.04
Marktkapitalisierung:
$419.14M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
+1.61%
1M Leistung:
+2.90%
6M Leistung:
+18.38%
1J Leistung:
+36.27%
1-Tages-Spanne:
$94.75
$96.36
1-Wochen-Bereich:
$92.97
$96.90
52-Wochen-Spanne:
$70.01
$98.82
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Firmenname
Invesco Biotechnology Genome Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare PBE vs VOO, IVV, SPY, VTI, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
96.36 | 419.14M | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
708.12 | 1.04T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
773.77 | 887.90B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
770.35 | 813.59B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
377.32 | 694.94B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
731.57 | 489.27B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf Aktie (PBE) Neueste Nachrichten
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Zacks Investment Research
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance UK
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Zacks Investment Research
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE? - The Motley Fool
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE? - The Globe and Mail
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE? - Yahoo Finance
How Invesco Dynamic Biotechnology & Genome Etf (PBE) Affects Rotational Strategy Timing - Stock Traders Daily
ETFs Investing in Legend Biotech Corp. Sponsored ADR Stocks - TradingView
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets - Benzinga
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Eastern Progress
PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? - The Motley Fool
PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? - The Globe and Mail
7 Best Biotech ETFs to Buy Now | Investing - US News Money
iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy? - The Motley Fool
PBE | Invesco Biotechnology & Genome Insider Trading - Quiver Quantitative
Biotech ETF Showdown: Why a 251-Stock Basket Is Beating Concentrated Rivals - finance.biggo.com
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? - The Motley Fool
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? - The Globe and Mail
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? - The Motley Fool
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? - The Globe and Mail
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? - Yahoo Finance
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Eastern Progress
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? - The Motley Fool
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? - Yahoo Finance
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? - The Globe and Mail
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - NewsBreak: Local News & Alerts
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance
XLV vs PBE: Healthcare Sector Stability vs Biotech Growth - sekbernews.id
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist? - theglobeandmail.com
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist? - The Motley Fool
PBE Dividend: 1.49% Yield, $1.55/Share — History & Dates - GuruFocus
Madrigal Pharmaceuticals Inc (MDGL) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Gilead Sciences Inc (GILD) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Sarepta Therapeutics Inc (SRPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bio-Techne Corp (TECH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vertex Pharmaceuticals Inc (VRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Invesco Biotechnology & Genome ETF : PBE - 24/7 Wall St.
Biotech ETFs XBI and PBE diverge sharply in str... - Pluang
ETF Showdown: XBI vs PBE, Which Biotech Fund Wins? - Yahoo Finance
ETF Showdown: XBI vs PBE, Which Biotech Fund Wins? - 24/7 Wall St.
Invesco Exchange-Traded Fund TrustInvesco Biotechnology & Genome ETF Reports Earnings Results for the Full Year Ended April 30, 2026 - marketscreener.com
PBEInvesco Biotechnology & Genome ETF Earnings - Finviz
PBEInvesco Biotechnology & Genome ETF Volatility & Greeks - Finviz
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.8106 - MSN
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.8106 - MSN
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.8106 - MSN
Madrigal Pharmaceuticals Inc (MDGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
United Therapeutics Corp (UTHR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Finanzdaten der Invesco Biotechnology Genome Etf-Aktie (PBE)
Es liegen keine Finanzdaten für Invesco Biotechnology Genome Etf (PBE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):